Live
- Heavy snow forecast in Japan through Tuesday
- Legendary film-maker Shyam Benegal is no more
- Hackers steal over $12.7 billion in over 1,000 crypto heists to date
- BGT: 'Rohit is short of confidence with self-doubts', opines Manjrekar
- Gold gains 30 pc in 2024, silver 35 pc up on COMEX this year: MOFSL
- Delhi HC dismisses anticipatory bail plea of ex-IAS trainee officer Puja Khedkar
- Untouched Goa Beaches You Must Visit in January
- Muzigal launches its State-of-the-art Music Academy in Nallagandla, Hyderabad
- Thoughtful Christmas Gifts for Every Loved One
- South Korea: Finance minister silent on martial law probe amid speculation on acting president's role
Zydus Cadila gets DCGI nod to initiate Phase-3 trials
Zydus Cadila gets DCGI nod to initiate Phase-3 trials
Highlights
Drug firm Zydus Cadila on Sunday said it has received DCGI approval to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D
New Delhi: Drug firm Zydus Cadila on Sunday said it has received DCGI approval to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D.
The company will now be initiating Phase III clinical trial in around 30,000 volunteers, Zydus Cadila said in a statement. ZyCoV-D was found to be safe, well-tolerated and immunogenic in phase I and II clinical trials, it added.
Next Story
ADVERTISEMENT
